Once-weekly efsitora noninferior to degludec for type 2 diabetes
By
HealthDay News
Sep 13, 2024
Once-weekly efsitora was noninferior to once-daily degludec for a decrease in the mean glycated hemoglobin level.
FDA expands use of breast cancer drug Kisqali
By
HealthDay News
Sep 18, 2024
The medication already was approved for advanced disease.
Low-dose triple-pill protocol lowers BP in Black Africans with hypertension
By
Haymarket Media
Sep 10, 2024
The mean home systolic blood pressure was lower with the triple-pill protocol versus the standard-care protocol at month 6.
Low-dose direct oral anticoagulants tied to more bleeding episodes
Jun 19, 2024
The findings compared with standard doses in patients with atrial fibrillation.
High-intensity statins underused with atherosclerotic cardiovascular disease
Sep 19, 2023
The authors say that the findings show gaps between practice and guideline-based care.
Loneliness linked to use of high-risk meds in seniors
Aug 06, 2021
Loneliness was associated with the use of NSAIDs, pain medicine, sedatives, anti-anxiety meds and antidepressants.
FDA approves Aurlumyn for severe frostbite
Feb 15, 2024
The newly approved medication lowers the need for amputation of fingers or toes.
Being in good shape tied to fewer mental health Rx
Sep 11, 2023
There was not an association noted between a reduced risk for medication use for adults aged 65 or more years.
ACP: Next-generation antibiotics underused for gram-negative infections
Apr 22, 2024
41.5% of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.